CoChat
Sign Up
Cited by 39

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Myeloid neoplasms in the setting of sickle cell disease: an intrinsic association with the underlying condition rather than a coincidence; report of 4 cases and review of the literature

Li, Yang, Maule, Jake, Neff, Jadee L., McCall, Chad M., Rapisardo, Sarah, Lagoo, Anand S., Yang, Lian-He, Crawford, Regina D., Zhao, Yue, Wang, Endi·2019·Modern Pathology
DOI 10.1038/s41379-019-0325-6
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41379-019-0325-6

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 27

  1. Gluckman, 2017, Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation, Blood, 129, 1548, 10.1182/blood-2016-10-745711 · DOI
  2. Arnold, 2016, Haematopoietic stem cell transplantation for sickle cell disease – current practice and new approaches, Br J Haematol, 174, 515, 10.1111/bjh.14167 · DOI
  3. Shenoy, 2017, Biol Blood Marrow Transpl, 23, 552, 10.1016/j.bbmt.2017.01.009 · DOI
  4. Seminog, 2016, Risk of individual malignant neoplasms in patients with sickle cell disease: English national record linkage study, J R Soc Med, 109, 303, 10.1177/0141076816651037 · DOI · Paper page
  5. Brunson, 2017, Increased risk of leukemia among sickle cell disease patients in California, Blood, 130, 1597, 10.1182/blood-2017-05-783233 · DOI · Paper page
  6. Aumont, 2015, Myelodysplastic syndrome with clonal cytogenetic abnormalities followed by fatal erythroid leukemia after 14 years of exposure to hydroxyurea for sickle cell anemia, Am J Hematol, 90, E131, 10.1002/ajh.24010 · DOI
  7. Zemenides, 2014, Peripheral blood features of acute myeloid leukemia with myelodysplasia-related changes developing in a patient with sickle cell anemia, Am J Hematol, 89, 1010, 10.1002/ajh.23768 · DOI
  8. Wilson, 2000, Acute leukemia in a patient with sickle-cell anemia treated with hydroxyurea, Ann Intern Med, 133, 925, 10.7326/0003-4819-133-11-200012050-00029 · DOI
  9. Baz, 2012, Development of myelodysplastic syndrome and acute myeloid leukemia 15 years after hydroxyurea use in a patient with sickle cell anemia, Clin Med Insights Oncol, 6, 149, 10.4137/CMO.S8810 · DOI
  10. Taylor, 2011, Therapy-related acute myelogenous leukemia in a hydroxyurea-treated patient with sickle cell anemia, Ann Intern Med, 155, 722, 10.7326/0003-4819-155-10-201111150-00024 · DOI
  11. Chen, 2005, Chronic myelogenous leukemia in sickle cell anemia, Arch Pathol Lab Med, 129, 423, 10.5858/2005-129-423-CMLISC · DOI
  12. Murphy, 2014, Effectiveness of imatinib therapy for sickle cell sanemia and chronic myeloid leukemia, Am J Med Sci, 347, 254, 10.1097/MAJ.0000000000000228 · DOI
  13. Sallam, 2011, Chronic myelogenous leukemia in sickle cell/beta 0 -thalassemia, Indian J Pathol Microbiol, 54, 597, 10.4103/0377-4929.85107 · DOI
  14. Stankovic Stojanovic, 2011, Chronic myeloid leukaemia and sickle cell disease: could imatinib prevent vaso-occlusive crisis?, Br J Haematol, 155, 271, 10.1111/j.1365-2141.2011.08670.x · DOI
  15. Janakiram, 2018, Accelerated leukemic transformation after haplo-identical transplantation for hydroxyurea-treated sickle cell disease, Leuk Lymphoma, 59, 241, 10.1080/10428194.2017.1324158 · DOI · Paper page
  16. Stricker, 1986, Hematologic malignancy in sickle cell disease: Report of four cases and review of the literature, Am J Hematol, 21, 223, 10.1002/ajh.2830210212 · DOI
  17. Smith, 2003, Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series, Blood, 102, 43, 10.1182/blood-2002-11-3343 · DOI
  18. Fianchi, 2015, Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias, Am J Hematol, 90, E80, 10.1002/ajh.23966 · DOI
  19. Claerhout, 2018, A monocentric retrospective study of 138 therapy-related myeloid neoplasms, Ann Hematol, 97, 2319, 10.1007/s00277-018-3462-y · DOI
  20. McNerney, 2017, Therapy-related myeloid neoplasms: when genetics and environment collide, Nat Rev Cancer, 17, 513, 10.1038/nrc.2017.60 · DOI
  21. Schoch, 2003, Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML, Leukemia, 18, 120, 10.1038/sj.leu.2403187 · DOI
  22. Ok, 2015, Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases, Leuk Res, 39, 348, 10.1016/j.leukres.2014.12.006 · DOI
  23. Saft, 2014, p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q), Haematologica, 99, 1041, 10.3324/haematol.2013.098103 · DOI
  24. McGraw, 2016, Immunohistochemical pattern of p53 is a measure of TP53 mutation burden and adverse clinical outcome in myelodysplastic syndromes and secondary acute myeloid leukemia, Haematologica, 101, e320, 10.3324/haematol.2016.143214 · DOI
  25. Crusz, 2015, Inflammation and cancer: advances and new agents, Nat Rev Clin Oncol, 12, 584, 10.1038/nrclinonc.2015.105 · DOI · Paper page
  26. Alves, 2008, Sensitivity to cisplatin-induced mutations and elevated chromosomal aberrations in lymphocytes from sickle cell disease patients, Clin Exp Med, 8, 31, 10.1007/s10238-008-0153-3 · DOI
  27. Zhang, 1988, Is rapid proliferation in B centroblasts linked to somatic mutation in memory B cell clones?, Immunol Lett, 18, 297, 10.1016/0165-2478(88)90178-2 · DOI

Cited by

See all 39

Metadata

Authors
Li, Y., Maule, J., Neff, J. L., McCall, C. M., Rapisardo, S., Lagoo, A. S., Yang, L.-H., Crawford, R. D., Zhao, Y., & Wang, E.
Venue
Modern Pathology
Publisher
Elsevier BV
Published
2019-12
Volume
32
Issue
12
Pages
1712-1726
ISSN
0893-3952
DOI
10.1038/s41379-019-0325-6
Cited by
39
References
3
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Myeloid neoplasms in the setting of sickle cell disease: an intrinsic association with the underlying condition rather than a coincidence; report of 4 cases and review of the literature. https://app.cochat.ai/papers/10.1038/s41379-019-0325-6
The paper
Li, Y., Maule, J., Neff, J. L., McCall, C. M., Rapisardo, S., Lagoo, A. S., Yang, L.-H., Crawford, R. D., Zhao, Y., & Wang, E. (2019). Myeloid neoplasms in the setting of sickle cell disease: an intrinsic association with the underlying condition rather than a coincidence; report of 4 cases and review of the literature. Modern Pathology. https://doi.org/10.1038/s41379-019-0325-6